Journal of Nuclear Medicine, The - FDA seeks NDAs fr Prussian blue to treat radiation exposure
April 1, 2003 -- On January 31 the Food and Drug Administration (FDA) issued a statement asking manufacturers to submit marketing applications for Prussian blue...
M2 Presswire - FDA encourages new drug application submissions for Prussian blue as a treatment for thallium or radioactive cesium contamination.
February 3, 2003 -- M2 PRESSWIRE-3 February 2003-US FDA: FDA encourages new drug application submissions for Prussian blue as a treatment for thallium or radioactive...
